INmune Bio Balance Sheet Health
Financial Health criteria checks 4/6
INmune Bio has a total shareholder equity of $38.7M and total debt of $2.5M, which brings its debt-to-equity ratio to 6.4%. Its total assets and total liabilities are $52.8M and $14.1M respectively.
Key information
6.4%
Debt to equity ratio
US$2.49m
Debt
| Interest coverage ratio | n/a |
| Cash | US$33.55m |
| Equity | US$38.68m |
| Total liabilities | US$14.11m |
| Total assets | US$52.78m |
Recent financial health updates
Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way?
Nov 03
Is INmune Bio (NASDAQ:INMB) Using Debt Sensibly?
Jan 19Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way?
Sep 04Is INmune Bio (NASDAQ:INMB) Using Too Much Debt?
May 12Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money
Jan 16Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money
Jul 11Recent updates
Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way?
Nov 03INmune Bio: NK Cell Therapy INKmune For mCRPC Is Another Shot On Goal
Sep 30It's Unlikely That Shareholders Will Increase INmune Bio, Inc.'s (NASDAQ:INMB) Compensation By Much This Year
Jul 12Is INmune Bio (NASDAQ:INMB) Using Debt Sensibly?
Jan 19Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way?
Sep 04Is INmune Bio (NASDAQ:INMB) Using Too Much Debt?
May 12Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money
Jan 16Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money
Jul 11INmune Bio: Possibly The Once In A Lifetime Dip
May 25INmune Bio: Speculative Biotech With 2 Solid Potential Approaches To Treating AD And Solid Tumors
Apr 05Is INmune Bio (NASDAQ:INMB) A Risky Investment?
Mar 25Financial Position Analysis
Short Term Liabilities: INMB's short term assets ($35.9M) exceed its short term liabilities ($13.8M).
Long Term Liabilities: INMB's short term assets ($35.9M) exceed its long term liabilities ($284.0K).
Debt to Equity History and Analysis
Debt Level: INMB has more cash than its total debt.
Reducing Debt: INMB's debt to equity ratio has increased from 0% to 6.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: INMB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: INMB has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.7% each year